Company Data
ProKidney Corp.
Ticker
PROK
Current Price
$0.705 -2.15%
Market Cap
$206.4M
Price Target
Refer to Report
Volume
244.0K
52wk Range
$0.4603 - $4.3499
Overview
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient’s own cells isolated from the patient intended for treatment. Its lead product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient’s own renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease.